PGR and neoplasm: The findings of Liu et al. suggested that DNA methylation and MED12 mutation together constitute a complex regulatory network that affects progesterone/PR-mediated RANKL gene expression, with an essential role in activating stem cell proliferation and fibroid tumor development [56].